XPENG INC - ADR (XPEV)

US98422D1054 - ADR

7.68  -0.13 (-1.66%)

After market: 7.73 +0.05 (+0.65%)

Buy % Consensus

73

ChartMill assigns a Buy % Consensus number of 73% to XPEV. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.56. This target is 128.63% above the current price.
XPEV was analyzed by 36 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about XPEV.
In the previous month the buy percentage consensus was at a similar level.
XPEV was analyzed by 36 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 7.687.3717.3417.5629.40 - -4.00% 125.78% 128.63% 282.81%
Up and Down Grades
Date Firm Action Rating
2024-03-11 Morgan Stanley Maintains Overweight -> Overweight
2024-02-23 JP Morgan Maintains Neutral -> Neutral
2023-09-22 Morgan Stanley Reiterate Overweight -> Overweight
2023-08-22 Barclays Maintains Underweight -> Underweight
2023-08-21 JP Morgan Maintains Neutral -> Neutral
2023-08-21 B of A Securities Upgrade Neutral -> Buy
2023-08-08 CLSA Upgrade Outperform -> Buy
2023-08-07 HSBC Upgrade Hold -> Buy
2023-08-02 Citigroup Maintains Sell -> Sell
2023-07-31 UBS Downgrade Buy -> Neutral
2023-07-28 Jefferies Upgrade Hold -> Buy
2023-07-21 JP Morgan Downgrade Neutral -> Underweight
2023-07-11 Goldman Sachs Initiate Buy
2023-07-07 BOCOM International Downgrade Neutral -> Sell
2023-06-30 CLSA Upgrade Buy -> Outperform
2023-06-16 B of A Securities Maintains Neutral
2023-05-25 Barclays Downgrade Equal-Weight -> Underweight
2023-05-25 B of A Securities Maintains Neutral -> Neutral
2023-04-25 Jefferies Upgrade Underperform -> Hold
2023-03-24 Bernstein Downgrade Outperform -> Market Perform
2023-01-11 JP Morgan Downgrade Overweight -> Neutral
2023-01-06 B of A Securities Downgrade Buy -> Neutral
2022-12-14 Daiwa Capital Downgrade Buy -> Sell
2022-12-13 HSBC Maintains Buy
2022-12-02 China Renaissance Downgrade Buy -> Hold
2022-11-28 Jefferies Downgrade Hold -> Underperform
2022-11-17 UBS Upgrade Neutral -> Buy
2022-10-28 Barclays Maintains Equal-Weight
2022-10-28 Citigroup Downgrade Buy -> Sell
2022-08-24 Barclays Downgrade Overweight -> Equal-Weight